Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

European Patient Summary

Patient
Name: Vávrová, , Ludmila,
DOB: 08-AUG-1940 (Age: 85)
Gender: female
ID: 1992-540676-1 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 04-DEC-2024

Problem list

Condition Onset Date Status
Ischemic heart disease 12-Oct-2016 active
Osteoporosis 22-Aug-2007 active
Dependent drug abuse 18-Mar-1999 active
Hyperlipidemia 27-May-1992 active
Chronic intractable migraine without aura 04-Nov-1990 active
Impacted molars 22-Aug-1990 active
Osteoarthritis of hip 06-Jan-1989 active
Chronic sinusitis 20-Sep-1938 active

Medication list

Medication Since Form Dosage Reason
Simvastatin 10 mg oral tablet 2024-12-04 - 1 tablet (10 mg) by mouth once daily Hyperlipidemia
Alendronic acid (as alendronate sodium) 10 mg oral tablet 2024-11-27 - 1 tablet (10 mg) once daily Osteoporosis (disorder)
Simvastatin 20 mg oral tablet 2016-10-19 - 1 tablet (20 mg) by mouth once daily -
Nitroglycerin 400 microgram/actuation sublingual spray 2016-10-19 - 400 micrograms per spray, use one spray under the tongue as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes -
Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet 2016-10-19 - 1 tablet (100 mg) once daily -
Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet 2008-02-15 - 1 tablet (75 mg) by mouth once daily -
Alteplase 100 MG Injection 2008-02-15 - 100 mg IV as a single dose -

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 27-Nov-2024
SARS-CoV-2 mRNA vaccine 02-Jun-2021
Clostridium tetani toxoid antigen adsorbed only vaccine product 24-Oct-2018

Procedure History list

Procedure Date Reason
Pre-discharge assessment 11-Jul-2021 -
Discharge from skilled nursing facility (procedure) 11-Jul-2021 -
Professional / ancillary services care 10-Jul-2021 -
Nursing care/supplementary surveillance 10-Jul-2021 -
Physical therapy procedure 07-Jul-2021 -
History AND physical examination 06-Jul-2021 -
Pelvis X-ray 06-Jul-2021 -
Admission to orthopedic department 06-Jul-2021 Closed fracture of hip
Initial patient assessment 06-Jul-2021 -
Development of individualized plan of care 06-Jul-2021 -
Occupational therapy 08-Mar-2020 -
Speech and language therapy regime 05-Mar-2020 -
Radiography of humerus 27-Feb-2020 -
Bone immobilization 27-Feb-2020 Fracture of forearm
Postoperative procedure education 10-Nov-2016 History of coronary artery bypass grafting (situation)
Stair-climbing test 10-Nov-2016 History of coronary artery bypass grafting (situation)
Walking exercise test 10-Nov-2016 History of coronary artery bypass grafting (situation)
Discharge to ward 10-Nov-2016 -
Discharge from hospital 10-Nov-2016 History of coronary artery bypass grafting (situation)
Electrocardiographic procedure 09-Nov-2016 -
Transfusion of fresh frozen plasma 09-Nov-2016 -
Plain X-ray of chest 09-Nov-2016 -
Removal of endotracheal tube 08-Nov-2016 -

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
Inadequate digital access affecting health care 2025-10-22 active environment

Care Plan

Active Planned Care / Goals Start Date Reason
Care plan 01-Jan-1998 -
Hyperlipidemia clinical management plan 17-Jun-1992 Hyperlipidemia
  • Achieve and maintain LDL cholesterol below 70 mg/dL to reduce cardiovascular risk.
  • Maintain total cholesterol below 200 mg/dL.
  • Maintain HDL cholesterol above 50 mg/dL.
  • Maintain triglycerides below 150 mg/dL.
Musculoskeletal care 06-Jan-1989 Osteoarthritis of hip
  • Reduce the severity of hip pain to a tolerable level for daily activities.
  • Increase range of motion in the affected hip to support independent ambulation.
  • Enable patient to perform basic activities of daily living (ADLs) such as dressing and bathing with minimal assistance.
Immunization Recommendation Due Date Reason
Vaccine product containing only Influenza virus antigen (medicinal product) 01-Oct-2025 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2024-11-27 2023-11-22
Body Height 170.6 cm 170.6 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 1 {score} 2 {score}
Body Weight 79.7 kg 79.7 kg
Body mass index (BMI) [Ratio] 27.4 kg/m2 27.4 kg/m2
Diastolic Blood Pressure 61 mm[Hg] 64 mm[Hg]
Systolic Blood Pressure 132 mm[Hg] 122 mm[Hg]
Heart rate 82 /min 80 /min
Respiratory rate 16 /min 14 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 04-DEC-2024 Reference Range Unit
Glucose [Mass/volume] in Blood 64.9 L 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 15.3 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 3.4 H 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.8 8.6 - 10.4 mg/dL
Sodium [Moles/volume] in Blood 142.2 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.5 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 110.2 H 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 21.2 L 22 - 32 mmol/L
Protein [Mass/volume] in Serum or Plasma 6.1 L 6.6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 4.4 3.5 - 5.5 g/dL
Globulin [Mass/volume] in Serum by calculation 3.0 2.2 - 3.7 g/L
Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 0.3 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 87.8 40 - 130 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 45.4 7 - 55 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 33.5 10 - 40 U/L
Cholesterol [Mass/volume] in Serum or Plasma 199.8 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 110.2 10 - 175 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 140.2 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 34.0 L 50 - 100 mg/dL

Device Use

Device Date (since)
Walker (physical object) 06-Jan-1989
Home nebulizer (physical object) 20-Sep-1938